The novel treatment of the medication represents a significant breakthrough in the management of diabetes mellitus type 2. Unlike existing therapies, tirzepatide affects two pathways – GLP-1 and the GIP hormone – https://tirzepatide-peptide033783.blogchaat.com/42373637/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment